3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Cardiovascular Diseases
1
Interventions
sofosbuvir-velpatasvir drug combination
1
amlodipine, atorvastatin drug combination
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vitamin B 6
1
Vitamin B 12
1
Tumor Necrosis Factor Inhibitors
1
Rosuvastatin Calcium
1
Progesterone
1
Omeprazole
1
Naproxen
1
Liraglutide
1
Gonadotropin-Releasing Hormone
1
Geritol
1
Folic Acid
1
Febuxostat
1
Estradiol
1
Colchicine
1
Cholecalciferol
1
Chocolate
1
Atorvastatin
1
Antirheumatic Agents
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cardiovascular Diseases
×
Geritol
×
Clear all
NCT02422745
2025-09-24
COSMOS
Brigham and Women's Hospital
Phase 4
Completed
21,442 enrolled
31 charts